Podcasts Science Journal of Clinical Oncology (JCO) Podcast An International Phase II Trial of Single-Agent Nivolumab for Hodgkin Lymphoma Relapsed or Refractory After Autologous Stem Cell Transplant

An International Phase II Trial of Single-Agent Nivolumab for Hodgkin Lymphoma Relapsed or Refractory After Autologous Stem Cell Transplant

Published: March 27, 2018, 8 p.m.

b'

This podcast describes the extended follow-up of the large International phase II CheckMate 205 study of single-agent nivolumab for patients with relapsed/refractory classical\\xa0Hodgkin lymphoma after failure from autologous stem cell transplant.

Read the related article on JCO.org.

'